BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan

Advanced Genomics APAC and Cancer Precision Medicine Partner to Launch GALEAS™ Bladder Cancer Screening Test in Japan

Advanced Genomics APAC Co., Ltd. (hereinafter referred to as "Advanced Genomics APAC," headquartered in Taiwan, Managing Director: Andy Chang) i...

January 14, 2025 | News

NEC and Biomy Partner to Advance AI-Powered Digital Pathology for Precision Cancer Care

NEC Corporation (NEC; TSE: 6701) and Biomy, Inc. (Biomy) have signed a Memorandum of Understanding (MoU) to form a joint marketing partnership aimed at adv...

January 10, 2025 | News

Human Metapneumovirus Sparks Concern Across Asia: India Joins Global Vigilance

The detection of Human Metapneumovirus (HMPV) in Karnataka, India, and a rising number of cases across Asia have prompted heightened vigilance among health...

January 06, 2025 | Analysis

Astellas Pharma Announces NMPA Approval of Zolbetuximab in China for Advanced Gastric and GEJ Cancer

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the National Medical Products Administration (N...

January 06, 2025 | News

JCR Pharmaceuticals and Modalis Therapeutics Advance CNS Gene Therapy Collaboration

JCR Pharmaceuticals Co., Ltd. and Modalis Therapeutics Corporation announced that they have validated the initial proof of concept in a jo...

January 06, 2025 | News

Japan Approves TEPOXX as First Antiviral Treatment for Orthopoxviruses, Including Smallpox, Mpox, and Cowpox

Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpox Japan Bi...

January 03, 2025 | News

I Peace Achieves Milestone of Manufacturing 100 GMP-Grade iPS Cell Lines

Leading GMP cell CDMO I Peace, Inc., specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the n...

December 31, 2024 | News

Takeda’s HYQVIA Becomes First Facilitated Subcutaneous Immunoglobulin Approved in Japan for Immune Deficiency Disorders

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] is the First and Only Facilitated Subcutaneous Immunoglobulin (f...

December 30, 2024 | News

Jadeite Medicines Transfers NDA for Odevixibat in PFIC to Ipsen for Commercialization in Japan

Jadeite Medicines Inc., (Jadeite Medicines) a clinical stage biopharmaceutical company headquartered in Tokyo, Japan (President & CEO, Eiichi Takahashi...

December 26, 2024 | News

Axcelead Drug Discovery Partners Joins Forces with Astellas Pharma to Advance Targeted Protein Degrader Research

Axcelead Drug Discovery Partners, Inc. announced today that it has entered into a drug discovery service agreement with Astellas Pharma, Inc. (HQ: Ch...

December 26, 2024 | News

Daiichi Sankyo and AstraZeneca Withdraw EU Application for Datopotamab Deruxtecan in NSCLC

Daiichi Sankyo and AstraZeneca have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DX...

December 25, 2024 | News

CellProthera and SKGH Forge Alliance to Advance CD34+ Cell Therapy for Ischemic Diseases in Japan

CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced a new memorandum of understanding with Shonan Kamakur...

December 13, 2024 | News

Asahi Kasei Pharma Expands Global Reach with Exclusive Anti-CX3CR1 Antibody License

Asahi Kasei Pharma has taken another significant step toward becoming a leading global specialty pharmaceutical company by entering an exclusive license ag...

December 12, 2024 | News

GHIT Fund and WHO Strengthen Partnership to Combat Neglected Tropical Diseases

The Global Health Innovative Technology (GHIT) Fund and the World Health Organization (WHO) have signed a memorandum of understanding (MoU) to furthe...

December 11, 2024 | News

Stay Connected